Education
About Us
Working with TipRanks
Follow Us
Genus PLC (GB:GNS)
LSE:GNS
GNS Stock Chart & Stats
Day’s Range― - ―
52-Week Range1,424.00p - 2,155.00p
Previous CloseN/A
Volume9.41K
Average Volume (3M)159.88K
Market Cap
£1.24B
Enterprise Value1.33B
Total Cash (Recent Filing)£25.00M
Total Debt (Recent Filing)£110.30M
Price to Earnings (P/E)147.6
Beta1.69
Next Earnings
Sep 04, 2025EPS EstimateN/A
Last Dividend Ex-Date
Mar 06, 2025Dividend Yield1.7%
Share Statistics
EPS (TTM)-0.06
Shares Outstanding66,036,540
10 Day Avg. Volume169,267
30 Day Avg. Volume159,882
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.93
Price to Cash Flow (P/CF)27.20
P/FCF Ratio26.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
1,962.50pPrice Target Upside5.28% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Genus plc News
PremiumCompany Announcements
Genus plc Appoints Andy Russell as New CFO
PremiumCompany Announcements
Genus plc Earnings Call Highlights Robust Growth Amid Challenges
PremiumCompany Announcements
Genus plc Announces Total Voting Rights Update
PremiumCompany Announcements
Genus CEO Sells Shares to Cover Tax Liabilities
PremiumCompany Announcements
Genus plc Reports Strong First Half Performance and Strategic AdvancesPremiumCompany Announcements
Genus plc Announces Board Changes as Professor Jason Chin RetiresPremiumCompany Announcements
Genus plc Updates on Total Voting Rights---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceGenus announced that adjusted profit before tax for the first half of FY25 will be at least £35m, which is ahead of expectations.
Growth ProspectsThe execution of VAP Phase 2 is on track, expected to further help ABS deliver significant profit growth.
Market SentimentA recent relief rally in the stock price reflects positive sentiment following prior weakness.
Bears Say
Economic ConditionsThere is caution due to continued economic weakness in China and the possibility of tariff wars, which could impact the business negatively.
Regulatory ChallengesUncertainty exists due to important regulatory and commercial hurdles for the PRP programme, affecting near-term confidence.
Stock RatingThe stock rating has been downgraded from Buy to Hold due to weaker sentiment and a cautious outlook.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.35% Insiders
12.80%
Mutual Funds
― Other Institutional Investors
79.35% Public Companies and
Individual Investors
GNS FAQ
What was Genus PLC’s price range in the past 12 months?
Genus PLC lowest share price was 1424.00p and its highest was 2155.00p in the past 12 months.
What is Genus PLC’s market cap?
Genus PLC’s market cap is £1.24B.
When is Genus PLC’s upcoming earnings report date?
Genus PLC’s upcoming earnings report date is Sep 04, 2025 which is in 155 days.
How were Genus PLC’s earnings last quarter?
Genus PLC released its earnings results on Feb 27, 2025. The company reported 0.394p earnings per share for the quarter, beating the consensus estimate of N/A by 0.394p.
Is Genus PLC overvalued?
According to Wall Street analysts Genus PLC’s price is currently Undervalued.
Does Genus PLC pay dividends?
Genus PLC pays a Annually dividend of 10.3p which represents an annual dividend yield of 1.7%. See more information on Genus PLC dividends here
What is Genus PLC’s EPS estimate?
Genus PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genus PLC have?
Genus PLC has 66,036,540 shares outstanding.
What happened to Genus PLC’s price movement after its last earnings report?
Genus PLC reported an EPS of 0.394p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -4.372%.
Which hedge fund is a major shareholder of Genus PLC?
Currently, no hedge funds are holding shares in GB:GNS
---
Genus plc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
1,962.50p (5.28% Upside)
1,962.50p (5.28% Upside)
Insider Transactions
Sold Shares
Worth £345.5K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
7.37%
12-Months-Change
Fundamentals
Return on Equity
-0.73%
Trailing 12-Months
Asset Growth
-6.45%
Trailing 12-Months
Company Description
Genus PLC
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers semen sexing, in reproductive, and other technical services to farmers. Genus plc has a strategic collaboration with Beijing Capital Agribusiness Co. Ltd to pursue the porcine reproductive respiratory syndrome virus resistant regulatory and development work in China. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.
---
GNS Stock 12 Month Forecast
Average Price Target
1,962.50p
▲(5.28% Upside)
Technical Analysis
Associated British Foods
―
Croda International
―
FDM Group (Holdings)
―
Halma plc
―
PZ Cussons
―
Best Analysts Covering GNS
1 Year
1 Year Success Rate
2/3 ratings generated profit
1 Year Average Return
+2.67%
reiterated a buy rating 6 months ago
Copying Damian McNeela's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +2.67% per trade.
---